Michael J. Graziano

Ph.D., DABT, Vice-President, Drug Safety Evaluation

Mike is Vice-President of Drug Safety Evaluation and is currently responsible for all GLP nonclinical safety testing at Bristol-Myers Squibb. He is also responsible for the BMS Veterinary Science organization which supports 3 main discovery sites in the US. Mike joined Bristol-Myers Squibb as Executive Director in 2003 and was promoted to Vice President in 2006. Prior to joining BMS, he was Director of Anticancer and Antibacterial Toxicology Programs at Pfizer Pharmaceutical Research, Ann Arbor, MI and with Parke-Davis Pharmaceutical Research Division/Warner-Lambert Company. Mike has 30 years of experience as a toxicologist in the pharmaceutical industry. He is author/co-author of 1 book and close to 100 scientific publications and abstracts, many dealing with the nonclinical safety of new therapeutic agents. Mike is represents BMS on several professional and industry consortiums including PhRMA Clinical and Preclinical Development Committee and the EFPIA Preclinical Safety Development Committee. He received a B.S. in Animal Science from Rutgers University, a M.S. in Veterinary Toxicology from Louisiana State University, a Ph.D. in Toxicology from the University of Kentucky, and was a Post-Graduate Research Toxicologist in Pesticide Chemistry and Toxicology, at the University of California-Berkeley. Mike is also a Diplomate of the American Board of Toxicology since 1990.